Page last updated: 2024-10-18

dihydroxyphenylalanine and Facial Palsy

dihydroxyphenylalanine has been researched along with Facial Palsy in 3 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mendell, JR1
Engel, WK1
Chase, TN1
Matthews, WB1
Claveria, LE1
Calne, DB1
Allen, JG1

Reviews

1 review available for dihydroxyphenylalanine and Facial Palsy

ArticleYear
Advances in neurology.
    The Practitioner, 1972, Volume: 209, Issue:252

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticoagulants; Anticonvulsants; Antihypertens

1972

Other Studies

2 other studies available for dihydroxyphenylalanine and Facial Palsy

ArticleYear
Modification by L-dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism.
    Lancet (London, England), 1970, Mar-21, Volume: 1, Issue:7647

    Topics: Brain; Dihydroxyphenylalanine; Dopamine; Eye Movements; Facial Paralysis; Humans; Male; Middle Aged;

1970
"On-off" phenomena related to high plasma levodopa.
    British medical journal, 1973, Jun-16, Volume: 2, Issue:5867

    Topics: Aged; Cognition Disorders; Dihydroxyphenylalanine; Facial Paralysis; Female; Humans; Intestinal Abso

1973